Quadrant Capital Group’s Antares Pharma, Inc. ATRS Stock Holding History

Quadrant Capital Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-89	Closed	–	–	2849
2022 Q1	$0	Buy	+89	New	+$323	﹤0.01%	2775
2021 Q4	–	Sell	-72	Closed	–	–	2775
2021 Q3	$0	Buy	+72	New	+$291	﹤0.01%	2721

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrant Capital Group's ATRS Position: Q2 2022 in Review

Quadrant Capital Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 89 shares.

Quadrant Capital Group first reported a position in ATRS in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Quadrant Capital Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Quadrant Capital Group sold 89 Antares Pharma, Inc. shares in Q2 2022.
Quadrant Capital Group first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 2 quarters.
Quadrant Capital Group's Antares Pharma, Inc. position peaked at $0 in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.